MA42186A1 - Antigen binding proteins that activate the leptin receptor - Google Patents

Antigen binding proteins that activate the leptin receptor

Info

Publication number
MA42186A1
MA42186A1 MA42186A MA42186A MA42186A1 MA 42186 A1 MA42186 A1 MA 42186A1 MA 42186 A MA42186 A MA 42186A MA 42186 A MA42186 A MA 42186A MA 42186 A1 MA42186 A1 MA 42186A1
Authority
MA
Morocco
Prior art keywords
antigen binding
activate
leptin receptor
binding proteins
binding fragments
Prior art date
Application number
MA42186A
Other languages
French (fr)
Other versions
MA42186B1 (en
Inventor
Jesper Gromada
Panayiotis Stevis
Judith ALTAREJOS
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2016/056465 external-priority patent/WO2017066204A1/en
Publication of MA42186A1 publication Critical patent/MA42186A1/en
Publication of MA42186B1 publication Critical patent/MA42186B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des anticorps et des fragments de liaison d'antigène d'anticorps qui se lient au récepteur de la leptine (lepr), et des procédés d'utilisation de ces derniers. Selon certains modes de réalisation, l'invention concerne des anticorps et des fragments de liaison d'antigène d'anticorps qui se lient à la lepr et activent la signalisation par la lepr. Selon d'autres modes de réalisation, l'invention concerne des anticorps et des fragments de liaison d'antigène d'anticorps qui se lThe present invention relates to antibodies and antibody antigen binding fragments that bind to the leptin receptor (lepr), and methods of using the same. In some embodiments, the invention provides antibodies and antibody antigen binding fragments that bind to lepr and activate lepr signaling. According to other embodiments, the invention relates to antibodies and antibody antigen binding fragments which are

MA42186A 2015-10-12 2016-10-11 Antigen binding proteins that activate the leptin receptor MA42186B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562240021P 2015-10-12 2015-10-12
PCT/US2016/056465 WO2017066204A1 (en) 2015-10-12 2016-10-11 Antigen-binding proteins that activate the leptin receptor

Publications (2)

Publication Number Publication Date
MA42186A1 true MA42186A1 (en) 2018-07-31
MA42186B1 MA42186B1 (en) 2019-08-30

Family

ID=61158540

Family Applications (1)

Application Number Title Priority Date Filing Date
MA42186A MA42186B1 (en) 2015-10-12 2016-10-11 Antigen binding proteins that activate the leptin receptor

Country Status (2)

Country Link
AR (2) AR106319A1 (en)
MA (1) MA42186B1 (en)

Also Published As

Publication number Publication date
MA42186B1 (en) 2019-08-30
AR106319A1 (en) 2018-01-03
AR115992A2 (en) 2021-03-17

Similar Documents

Publication Publication Date Title
MA40801A1 (en) Anti-cd3 antibody, anti-cd123 antibody and bispecific antibodies binding specifically to cd3 and / or cd123
MX2021003393A (en) Sirpî± binding proteins and methods of use thereof.
PH12018502601A1 (en) Anti-b7-h3 antibodies and antibody drug conjugates
MX2018016265A (en) Heterodimeric antibodies that bind somatostatin receptor 2.
CL2023000895A1 (en) Chimeric dll3 receptors and methods for their use
PH12018501882A1 (en) Binding proteins and methods of use thereof
MA40609B1 (en) Cd123 binding agents and their uses
EA201891066A1 (en) ANTIBODIES TO ROR1
MA38498B1 (en) Anti-lag-3 binding proteins
EA201291181A1 (en) COMPOSITIONS AND METHODS OF APPLICATION OF THERAPEUTIC POLYVALENT ANTIBODIES AGAINST PROTEIN RELATED TO LOW DENSITY 6 LIPOPROTEIN RECEPTOR (LRP6)
EA201491599A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
BR112018075653A2 (en) anti-b7-h3 antibodies and drug antibody conjugates
CL2012003245A1 (en) Isolated antigen binding protein that binds to thymic stromal lymphopoietin (tslp); A composition comprising an antigen-binding protein that binds tslp corresponding to a human anti-tslp antibody.
EA201390146A1 (en) ANTIBODIES TO MATRIX METALLOPROTEINASE 9
MX2018015285A (en) Anti-b7-h3 antibodies and antibody drug conjugates.
MA35740B1 (en) Compositions and methods for antibodies targeting the factor p
MA34004B1 (en) Protein link cd127
AU2018338322A1 (en) A33 antibody compositions and methods of using the same in radioimmunotherapy
PH12014501931A1 (en) Antibodies to matrix metalloproteinase 9
EP4249511A3 (en) Anti-pd-l1/anti-lag3 bispecific antibodies and uses thereof
EA201791691A1 (en) SINGLE-DOMAIN ANTIBODIES DIRECTED TO CD1d
MX2022009915A (en) Anti-ror2 antibodies, antibody fragments, their immunoconjugates and uses thereof.
EA202092508A1 (en) COMPOSITIONS BASED ON ANTIBODIES TO HUMAN PD-L1
BR112021023540A2 (en) affinity agents
CL2023001064A1 (en) Anti-steap1 antigen binding protein